| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AI improves diagnostic accuracy and patient outcomes by quickly and accurately identifying abnormalities in medical images. This reduces the risk of human error, allows for earlier detection of diseases, and supports radiologists in making more informed decisions. As a result, patient care is enhanced through more timely and precise interventions. |
AI in medical imaging leverages machine learning and deep learning algorithms to analyze large datasets of medical images. These algorithms learn to recognize patterns and features associated with specific medical conditions, improving their accuracy over time. The theoretical foundation includes neural networks, pattern recognition, and data analysis. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A key benefit of AI in radiology is that it acts as a second medical opinion. By providing an additional layer of analysis, AI can help radiologists verify their diagnoses, reduce the likelihood of errors, and ensure more accurate and reliable results. This collaboration between AI and radiologists enhances diagnostic confidence and improves patient care outcomes. |
AI in radiology employs advanced algorithms to assist in the interpretation of medical images. The technology is built on principles of machine learning and deep learning, which enable systems to learn from large datasets and improve their accuracy in identifying patterns and anomalies in imaging data. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to the article, AI literacy refers to the understanding and knowledge of AI technology. This means being familiar with how AI works, its applications, benefits, and limitations. Developing AI literacy is essential for effectively implementing AI solutions, making informed decisions about their use, and addressing any ethical or practical challenges that may arise.
|
AI literacy involves understanding the principles and applications of AI technology. This includes knowledge of how AI algorithms work, their potential uses, limitations, and the ethical considerations surrounding their deployment. AI literacy encompasses both technical and contextual knowledge to effectively interact with and utilize AI systems. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The factor not listed as influencing the acceptability of AI among healthcare professionals is the color of the AI machines. While factors such as trust in AI systems, system understanding, technology receptiveness, and integration with existing workflows are critical in determining the acceptance and effective use of AI, the physical appearance, such as the color of the machines, is not considered relevant. |
Acceptability of AI among healthcare professionals is influenced by various factors, including trust in AI systems, understanding of how these systems work, receptiveness to new technologies, and the seamless integration of AI with existing workflows. These factors collectively determine how comfortably and effectively healthcare professionals can adopt and utilize AI technologies in their practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Determines the financial budget for AI |
|
The factor not listed as influencing the acceptability of AI among healthcare professionals is determines the financial budget for AI. Factors such as shaping how AI is marketed, influencing AI's diagnostic accuracy, and affecting healthcare professionals’ decisions to use AI are all relevant to the acceptability and adoption of AI in healthcare settings. However, the financial budget for AI, while important for implementation, is not directly related to the professionals' acceptability of the technology. |
Acceptability of AI among healthcare professionals depends on several factors, such as the system's diagnostic accuracy, the impact on clinical decision-making, and the integration into existing workflows. These factors influence how healthcare professionals perceive and adopt AI technologies in their practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A perceived threat regarding AI usage in healthcare settings is concerns about replacing healthcare professionals. This worry stems from the belief that AI might automate tasks traditionally performed by humans, leading to job displacement. While AI is designed to assist and augment the capabilities of healthcare professionals, the fear of job loss and reduced human involvement remains a significant concern among the workforces.
|
AI usage in healthcare is guided by principles of efficiency, accuracy, and enhanced patient care. However, its integration raises concerns about the potential impact on the workforce and patient interactions. Understanding these dynamics is crucial for addressing apprehensions and ensuring the smooth adoption of AI technologies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
According to the article, what is essential for increasing AI acceptability among medical professionals is designing human-centered AI systems. This involves creating AI technologies that prioritize user experience, ease of integration into current workflows, and address the specific needs and concerns of healthcare professionals. By focusing on human-centered design, AI systems can gain greater acceptance and trust from those who use them daily. |
Increasing AI acceptability among medical professionals involves creating systems that align with the needs and workflows of these professionals. The focus is on designing AI that integrates seamlessly into existing practices, supports human decision-making, and addresses the practical and ethical concerns of users. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
According to the article, the 'system usage' category of AI acceptability factors includes factors like value proposition and integration with workflows. This category covers how well the AI system fits into the current practices, its perceived benefits, and how seamlessly it can be incorporated into daily operations without causing disruptions. These aspects are crucial for ensuring that healthcare professionals find the AI system valuable and easy to adopt in their practice. |
AI acceptability factors include various aspects that influence how healthcare professionals perceive and utilize AI systems. These factors encompass the value proposition of AI, its integration with existing workflows, and the overall utility and ease of use within the healthcare setting. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality impacts AI acceptability among healthcare professionals by affecting views on AI based on compatibility with professional values. Healthcare professionals are more likely to adopt AI systems that align with their ethical standards and values, ensuring patient safety, privacy, and fairness. If AI systems are perceived as ethical, they are more likely to be trusted and accepted by professionals who prioritize ethical considerations in their practice. |
Ethicality in AI usage involves principles like fairness, transparency, and accountability. Ensuring AI systems align with ethical standards is crucial in fostering trust and confidence among users, particularly in sensitive fields like healthcare where patient well-being is paramount.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
None of the above |
|
The article emphasized considering user experience and system integration deeply for future AI acceptability studies. This approach ensures that research addresses how well AI systems fit into existing workflows and how they affect the overall experience of users. By focusing on these aspects, studies can provide insights into practical challenges and facilitate better adoption of AI technologies in healthcare settings. |
Methodological approaches in studying AI acceptability involve examining how well AI systems are integrated into existing practices and how they affect user experience. Research should consider the practical, social, and ethical dimensions of AI deployment to provide a comprehensive understanding of its impact. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
The primary objective of using human embryonic stem cells in treating Parkinson’s disease is to replace lost dopamine neurons. Parkinson's disease is characterized by the degeneration of dopamine-producing neurons in the brain. By using stem cells to generate and transplant new dopamine neurons, the aim is to restore normal function and alleviate symptoms associated with the disease. |
Human embryonic stem cells have the potential to differentiate into various cell types, including neurons. In treating neurodegenerative diseases like Parkinson's, the focus is on leveraging this capability to replace specific types of cells that are lost or damaged, such as dopamine-producing neurons. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
The animal used to test the STEM-PD product for safety and efficacy was monkeys. Monkeys are often chosen for such studies due to their closer physiological and neurological similarities to humans compared to other animals. This allows for a more accurate assessment of how the treatment might perform in human patients. |
Testing new medical products, such as stem cell therapies, often involves using animal models to assess safety and efficacy before clinical trials in humans. The choice of animal model depends on factors such as similarity to human physiology and the specific aspects of the treatment being tested. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
12 months |
|
The duration of the preclinical safety study in rats mentioned in the article was 12 months. This period allows researchers to observe the effects of the treatment over an extended timeframe, providing a comprehensive assessment of its safety and any potential long-term impacts before moving on to human trials. |
Preclinical safety studies are conducted to evaluate the long-term safety and potential side effects of a new treatment or intervention. The duration of these studies is crucial for assessing how the treatment behaves over time and identifying any delayed adverse effects. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The clinical trial phase mentioned for STEM-PD is Phase I/IIA. This phase combines elements of both Phase I and Phase II trials, aiming to evaluate the safety and preliminary efficacy of the treatment. It is designed to gather initial data on how well the treatment works and to refine its dosing and administration protocols. |
Clinical trial phases are stages in the development of new treatments that assess safety, efficacy, and optimal dosing. Each phase builds on the previous one, with Phase I focusing on safety, Phase II on efficacy, and Phase III on comparing the treatment with standard therapies before approval. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured under GMP-compliant conditions. GMP standards ensure that the product is produced consistently and meets quality standards, which is essential for clinical trials and eventual therapeutic use. Compliance with these conditions is crucial for maintaining safety and efficacy in the manufacturing process. |
Manufacturing of medical products, especially those intended for clinical use, must adhere to specific regulatory standards to ensure safety and quality. Good Manufacturing Practice (GMP) guidelines are critical in maintaining consistency and meeting regulatory requirements. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
According to the article, the safety of the STEM-PD product in rats was confirmed by there being no adverse effects or tumor formation. This finding indicates that the product did not cause significant harm or undesirable side effects, which is crucial for progressing to further stages of development and testing.
|
Confirming the safety of a medical product in preclinical studies involves assessing various potential adverse effects, such as tumor formation, immune reactions, or improper biodistribution of cells. A key goal is to ensure that the product does not cause harmful outcomes before advancing to human trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
A key finding noted in the efficacy study of STEM-PD in rats was that transplanted cells reversed motor deficits in rats. This result demonstrates that the stem cell therapy was effective in addressing the specific motor impairments associated with the condition being studied, indicating potential therapeutic benefits.
|
In efficacy studies, the focus is on determining whether the treatment produces the desired therapeutic effects. For stem cell therapies, this typically involves assessing whether the transplanted cells achieve the intended functional outcomes, such as restoring lost functions or alleviating symptoms. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
The specific markers used to assess the purity of the STEM-PD batch were GIRK2 and ALDH1A1. These markers are indicative of the presence and purity of dopamine neurons, which are crucial for evaluating the quality and suitability of the stem cell product for therapeutic use. |
Assessing the purity of stem cell batches involves using specific markers to ensure that the cells are of the correct type and have the desired characteristics. These markers are often associated with particular stages of cell differentiation or specific cell types. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
In the manufacturing process of STEM-PD, growth factors like FGF8b and SHH are used in cell patterning for specific neural fates. These factors help guide the stem cells to differentiate into the desired types of neural cells, such as dopamine neurons, which are essential for the therapeutic goals of the product. |
Growth factors are crucial in stem cell manufacturing as they guide the differentiation process by influencing cell development into specific lineages. In neural stem cell therapy, growth factors help in directing cells to develop into particular types of neurons or other neural cells. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
A key outcome measured in the preclinical trials for efficacy in rats was recovery of motor function. This outcome indicates whether the treatment was successful in restoring motor abilities, which is a primary goal in studies involving conditions that affect motor skills, such as Parkinson's disease. |
In preclinical trials, efficacy outcomes are measured to determine if the treatment achieves the desired therapeutic effects. For neurological therapies, key outcomes often focus on functional recovery or improvement in symptoms related to the condition being treated. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|